Joseph S. McCracken - 16 Feb 2026 Form 4 Insider Report for Savara Inc (SVRA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Feb 2026, 17:30:13 UTC
Prior SEC filing
11 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Lowrance as attorney-in-fact for Joseph S. McCracken

Key filing fact

Joseph S. McCracken filed Form 4 for Savara Inc (SVRA) on 17 Feb 2026.

Key facts

  • This page summarizes Joseph S. McCracken's Form 4 filing for Savara Inc (SVRA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Feb 2026, 17:30.

Change

  • Previous filing in this sequence was filed on 11 Dec 2025.
  • Current net transaction value: +$3,180.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001632454 Primary reporting owner

McCracken Joseph S

Relationship
Director
Address
ONE SUMMIT SQUARE,, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300, LANGHORNE
Signature
/s/ David Lowrance as attorney-in-fact for Joseph S. McCracken
Signature date
17 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SVRA transaction

Common Stock

Options Exercise

Transaction value
$3,180
Shares
+1,807
Change %
+0.6%
Price
$1.76
Shares after
302,644
Date
16 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SVRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-1,807
Change %
-100%
Price
$0.000000
Shares after
0
Date
16 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,807
Exercise price
$1.76
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2017.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .